Literature DB >> 16292333

Effect of sildenafil on ocular hemodynamics in 3 months regular use.

S O Dündar1, Y Dayanir, A Topaloğlu, M Dündar, I Koçak.   

Abstract

The aim of this study was to evaluate the effect of sildenafil on ocular hemodynamics in a group of men with erectile dysfunction in 3 months regular use. A total of 15 patients with erectile dysfunction were included in this prospective study. All patients received 50 mg doses of sildenafil (Viagra, Pfizer) two times per week regularly for 3 months. The following examinations were performed on both eyes before and after sildenafil treatment: best-corrected visual acuity (BCVA), intraocular pressure (IOP), color vision, anterior segment, and fundus examination. Using color Doppler imaging, we measured hemodynamic variables in the ophthalmic artery (OA), central retinal artery (CRA), and short posterior ciliary artery (SPCA). No significant changes in BCVA, color vision and IOP were found after sildenafil treatment. The anterior segment and fundus examinations showed no abnormalities. All Doppler parameters of OA, CRA, and SPCA remained nonsignificant for both eyes after sildenafil treatment. Oral sildenafil in 3 months regular use seems to have no effect on ocular hemodynamics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16292333     DOI: 10.1038/sj.ijir.3901416

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  9 in total

1.  Effect of sildenafil citrate on intraocular pressure and blood pressure in human volunteers.

Authors:  Rosana Gerometta; Lawrence J Alvarez; Oscar A Candia
Journal:  Exp Eye Res       Date:  2011-05-30       Impact factor: 3.467

Review 2.  Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure.

Authors:  Joshua C Baker; Robert Fintelmann; Roohollah Sharifi; Mary Lee
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

Review 3.  Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Authors:  Alan M Laties
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 4.  Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?

Authors:  Konstantinos Hatzimouratidis
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 3.092

Review 5.  Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma.

Authors:  Emmanuel S Buys; Lincoln R Potter; Louis R Pasquale; Bruce R Ksander
Journal:  Front Mol Neurosci       Date:  2014-05-19       Impact factor: 5.639

Review 6.  Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction.

Authors:  Marilita M Moschos; Eirini Nitoda
Journal:  Drug Des Devel Ther       Date:  2016-10-19       Impact factor: 4.162

7.  Sildenafil dilates ophthalmic artery in type 2 diabetic patients.

Authors:  Akeel Amh Zwain; Najah R Hadi; Ahmed M Al-Mudhaffer
Journal:  SAGE Open Med       Date:  2013-08-20

8.  Ocular perfusion pressure and color Doppler imaging of the external ophthalmic artery of rabbits treated with sildenafil citrate.

Authors:  Ana Paula Araujo Costa; Aline Maria Vasconcelos Lima; Luiz Henrique da Silva; Rosângela de Oliveira Alves Carvalho; Andréia Vitor Couto do Amaral; Naida Cristina Borges
Journal:  BMC Vet Res       Date:  2016-07-22       Impact factor: 2.741

Review 9.  Visual Side Effects Linked to Sildenafil Consumption: An Update.

Authors:  Eva Ausó; Violeta Gómez-Vicente; Gema Esquiva
Journal:  Biomedicines       Date:  2021-03-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.